Definitive Healthcare Corp. (NASDAQ:DH – Get Free Report) has received an average recommendation of “Reduce” from the ten ratings firms that are presently covering the firm, MarketBeat reports. Two equities research analysts have rated the stock with a sell recommendation, seven have issued a hold recommendation and one has issued a buy recommendation on the company. The average 1 year target price among analysts that have updated their coverage on the stock in the last year is $5.10.
DH has been the topic of several analyst reports. BTIG Research cut shares of Definitive Healthcare from a “buy” rating to a “neutral” rating in a report on Friday, May 9th. Wall Street Zen upgraded shares of Definitive Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, June 21st. Finally, The Goldman Sachs Group lifted their price objective on shares of Definitive Healthcare from $3.00 to $3.40 and gave the stock a “neutral” rating in a research report on Monday, May 12th.
Read Our Latest Research Report on Definitive Healthcare
Institutional Trading of Definitive Healthcare
Definitive Healthcare Stock Up 1.8%
Shares of NASDAQ DH opened at $4.02 on Thursday. The stock has a market cap of $597.53 million, a P/E ratio of -0.92, a PEG ratio of 6.65 and a beta of 1.64. The business’s fifty day simple moving average is $3.65 and its 200-day simple moving average is $3.64. Definitive Healthcare has a 12-month low of $2.15 and a 12-month high of $6.16. The company has a current ratio of 1.75, a quick ratio of 1.75 and a debt-to-equity ratio of 0.37.
Definitive Healthcare (NASDAQ:DH – Get Free Report) last posted its quarterly earnings results on Thursday, May 8th. The company reported $0.05 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.02 by $0.03. The company had revenue of $59.19 million for the quarter, compared to analyst estimates of $56.20 million. Definitive Healthcare had a positive return on equity of 3.69% and a negative net margin of 206.05%. Definitive Healthcare’s revenue for the quarter was down 6.8% compared to the same quarter last year. During the same quarter last year, the company earned $0.08 EPS. As a group, equities analysts predict that Definitive Healthcare will post 0.16 EPS for the current fiscal year.
Definitive Healthcare Company Profile
Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.
Read More
- Five stocks we like better than Definitive Healthcare
- Insider Buying Explained: What Investors Need to Know
- 3 Stocks to Cushion Your Portfolio This Earnings Season
- What is Insider Trading? What You Can Learn from Insider Trading
- This Fund Manager Says You Should Get Out of Tesla and Apple—Now
- Upcoming IPO Stock Lockup Period, Explained
- JNJ’s Stock Price Is Back in Rally Mode—The Time to Buy Is Now
Receive News & Ratings for Definitive Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Definitive Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.